Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 103 results found. Search for [ Bharat Biotech ]

Results 1 to 21 of 103
PB Jayakumar
New Delhi, July 3, 2020
Industry experts say this could be only an aspirational target and directive to speed up the trials, than a realistic move to get the vaccine launched within one and a half months


BusinessToday.In
July 3, 2020
Coronavirus vaccine update: A coronavirus vaccine candidate tested by American firm Pfizer and German biotech major BioNTech SE has been found to generate antibodies in people, a study showed


BusinessToday.In
New Delhi, July 3, 2020
Indian Council of Medical Research (ICMR) expects to launch Bharat Biotech's COVAXIN by August 15. ICMR has selected 12 institutes for the clinical trial, according to an official. The institutes have been asked by ICMR to fast track the trials. Watch the video for more.Coronavirus crisis: Ban on international flights extended till July 31


E Kumar Sharma
July 3, 2020
Zydus Cadila is second in India after Bharat Biotech to receive DCGI nod for human trials of vaccine candidate


BusinessToday.In
July 3, 2020
Coronavirus vaccine update: ICMR asked the institutes to ensure that all the subjects are enrolled starting this week and to speed up approvals


BusinessToday.In
July 3, 2020
Maharashtra Mumbai, Delhi Coronavirus (COVID-19) cases, Lockdown News Pune, Thane Live Updates: ICMR writes to Bharat Biotech to conclude trials of COVID-19 vaccine in order to launch the results by August 15. India's total coronavirus cases jumped to 6,25,544 on Friday. Maharashtra's tally is past 1.86 lakh while Tamil Nadu and Delhi count stands at 98,392 and 92,175


PTI
July 3, 2020
Coronavirus vaccine update: The approval process was fast-tracked following a recommendation by the subject expert committee on COVID-19, considering the emergency and unmet medical need during the pandemic


Joe C Mathew
July 2, 2020
\"Availability and monitoring of prices of critical medical equipment for COVID-19 was on the agenda of the meeting\", an industry representative said


BusinessToday.In
July 2, 2020
Coronavirus Vaccine Latest News: With the news of the Oxford University-AstraZeneca vaccine in its last stage of clinical trials, hopes are high for an earlier than expected arrival of a COVID-19 vaccine


Nidhi Singal
New Delhi, July 1, 2020
The new service seems to be based on the insights of the Spotify user study. Spotify found that 73 per cent of couples say they listen to music together as a way of remembering happy memories


Niti Kiran
New Delhi, July 1, 2020
In India, economic growth cycle coincides with the investment cycle. A component-wise analysis of GDP suggests that the growth rate of real investment decelerated sharply after 2011-12


Naveen Kumar
New Delhi, July 1, 2020
People who have missed the rally are wondering if they should invest now. Many investors with good exposure to the yellow metal are pondering over liquidating and locking in some gains


E Kumar Sharma
July 1, 2020
Bharat Biotech isn't committing a timeline, but considering the necessary processes, and if COVAXIN does not fail at any stage, the earliest it could hit the market is late 2021


BusinessToday.In
June 30, 2020
Coronavirus vaccine update: The Hyderabad-based vaccine major's vaccine candidate COVAXIN has received permission for advancing to human trials


E Kumar Sharma
June 29, 2020
DCGI has allowed Bharat Biotech to conduct phase I and II human trials for COVAXIN that will begin in July; a finished vaccine is expected to be rolled out in 3-4 months if all goes according to plan


PB Jayakumar
New Delhi, June 9, 2020
Whether India develops a Covid-19 vaccine/drug or not, Indian companies will be preferred partners for global pharma to make and distribute the life-saving drug globally


E Kumar Sharma
New Delhi, June 3, 2020
This grant is supported by the European Union (EU)'s Horizon 2020 programme through an existing framework partnership agreement with CEPI


BusinessToday.In
New Delhi, May 31, 2020
Relying on developing herd immunity to fight coronavirus is \"too large a risk\" for any nation and only timely interventions can contain the spread of deadly virus, says Shekhar Mande, Director General of CSIR


BusinessToday.In
New Delhi, May 31, 2020
Coronavirus vaccine update: Over 100 experimental COVID-19 vaccines are in various stages of development; from US-based Moderna Inc to China's CanSino Pharmaceuticals -- some of the world's biggest companies are in race to develop coronavirus vaccine


BusinessToday.In
New Delhi, May 30, 2020
Coronavirus vaccine update: Novavax is buying SII's manufacturing plant and planning to produce a billion doses of its coronavirus vaccine by next year


PAGES 1 OF 6  12345